Sanofi takes a bold step by acquiring Blueprint MedicinesSanofi Makes Bold Move with $9.5 Billion Acquisition of Blueprint Medicines
By Ion Jauregui – Analyst at ActivTrades
French pharmaceutical giant Sanofi (EPA:SAN) has kicked off 2025 with a bold strategic move: the acquisition of U.S.-based biotech Blueprint Medicines (NASDAQ:BPMC) for up to $9.5 b
6.40 EUR
7.81 B EUR
43.63 B EUR
1.11 B
About Sanofi SA
Sector
Industry
CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
IPO date
Jul 1, 2002
Identifiers
2
ISIN FR0000120578
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
Related stocks
Short on SANOFI (SAN)Short until 87.0 (support zone).
Strong selling pressure confirmed by two large red candles.
Recent green candle shows buyer hesitation (small body, upper wick).
No significant volume to support a bullish rebound.
RSI remains weak but needs surveillance.
Rebound lacking conviction.
Sanofi (SNY): A Strong Investment CaseCompany Overview:
Sanofi NASDAQ:SNY is a major pharmaceutical company based in Paris, with a market capitalization of $134 billion.
Investment Highlights:
Dividend Yield: 3.8%, more than double the S&P 500 average.
Drug Portfolio: Diverse and includes successful drug developments.
Pipeline: Prom
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SNY6217374
Sanofi SA 4.2% 03-NOV-2032Yield to maturity
4.17%
Maturity date
Nov 3, 2032
SNY6217372
Sanofi SA 3.8% 03-NOV-2028Yield to maturity
3.82%
Maturity date
Nov 3, 2028
US801060AD6
Sanofi SA 3.625% 19-JUN-2028Yield to maturity
3.76%
Maturity date
Jun 19, 2028
SNY6217370
Sanofi SA 3.75% 03-NOV-2027Yield to maturity
3.59%
Maturity date
Nov 3, 2027
FR1332437
Sanofi SA 1.875% 21-MAR-2038Yield to maturity
3.49%
Maturity date
Mar 21, 2038
FR1340985
Sanofi 1.25% 21-MAR-2034Yield to maturity
3.12%
Maturity date
Mar 21, 2034
FR14010MR
Sanofi SA 3.0% 23-JUN-2032Yield to maturity
2.94%
Maturity date
Jun 23, 2032
FR1400Y1I
Sanofi SA 2.75% 11-MAR-2031Yield to maturity
2.83%
Maturity date
Mar 11, 2031
FR14010MQ
Sanofi SA 2.625% 23-JUN-2029Yield to maturity
2.58%
Maturity date
Jun 23, 2029
FR1350511
Sanofi 1.5% 01-APR-2030Yield to maturity
2.56%
Maturity date
Apr 1, 2030
FR1332435
Sanofi SA 1.375% 21-MAR-2030Yield to maturity
2.53%
Maturity date
Mar 21, 2030
See all SANP bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Sanofi SA stocks are traded under the ticker SANP.
We've gathered analysts' opinions on Sanofi SA future price: according to them, SANP price has a max estimate of 119.00 EUR and a min estimate of 78.00 EUR. Watch SANP chart and read a more detailed Sanofi SA stock forecast: see what analysts think of Sanofi SA and suggest that you do with its stocks.
SANP reached its all-time high on Mar 10, 2025 with the price of 110.86 EUR, and its all-time low was 62.91 EUR and was reached on Mar 26, 2018. View more price dynamics on SANP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Sanofi SA financials in yearly and quarterly reports right on TradingView.
SANP net income for the last half-year is 2.00 B EUR, while the previous report showed 5.81 B EUR of net income which accounts for −65.57% change. Track more Sanofi SA financial stats to get the full picture.
Yes, SANP dividends are paid annually. The last dividend per share was 3.92 EUR. As of today, Dividend Yield (TTM)% is 4.96%. Tracking Sanofi SA dividends might help you take more informed decisions.
Like other stocks, SANP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi SA stock right from TradingView charts — choose your broker and connect to your account.









